15 (S)-15-methyl-prostaglandin F2alpha: myometrial response and abortifacient efficacy.
D000028:Abortion, Induced; D000650:Amnion; D002584:Cervix Uteri / Q000187:drug effects; D003967:Diarrhea / Q000139:chemically induced; D004106:Dilatation; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D009129:Muscle Tonus / Q000187:drug effects; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011460:Prostaglandins F / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors; D014590:Uterine Contraction / Q000187:drug effects; D014839:Vomiting / Q000139:chemically induced
D011460:Prostaglandins F